SymPhysis Medical

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia, H91 DCH9

Company profile

SymPhysis Medical company profile

SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life. About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
H91 DCH9
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
6
Total equity funding
$6.1M
Last funding
Grant / $1.3M / 2025-11-25
Last equity funding
Series Unknown / $2.4M
Investors
9
Lead investors
3
Articles
28

Founders and investors

Lead investors

HBANMedTech InnovatorRI Life Science Hub

Investors

Enterprise IrelandFurthr VCHBANIrrus InvestmentsMedTech Innovator